TrialOncology2019

A Phase 2 Study of PCI-27483, a Factor VIIa Inhibitor in Combination with Gemcitabine for Advanced Pancreatic Cancer.

Ramesh K Ramanathan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.